Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark Schoenebaum currently holds 125,949 shares of TG THERAPEUTICS, INC. (TGTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Schoenebaum has been a net neutral trader of TGTX stock. They have purchased $0 and sold $0 worth of shares.
Mark Schoenebaum's most recent insider trade was on Jun 26, 2018, when they sold 15,000 shares at $0.00 per share.
Mark Schoenebaum serves as Executive at TG THERAPEUTICS, INC. (TGTX). They have executed 8 insider transactions totaling $0 over their tenure at the company.
Mark Schoenebaum holds the position of Executive at TG THERAPEUTICS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
Mark Schoenebaum has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Mark Schoenebaum was on Jun 26, 2018, when they purchased $0 worth of TGTX shares. This transaction involved 15,000 shares at N/A per share.
Mark Schoenebaum currently owns 125,949 shares of TG THERAPEUTICS, INC. (TGTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark Schoenebaum's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark Schoenebaum has 8 Form 4 filings on record as an insider at TG THERAPEUTICS, INC..
Set alerts for Mark Schoenebaum and 40,000+ other insiders.